Seòmar agus comataidhean

This information is not held centrally .

This information requested is not currently available.

With the British Heart Foundation Data Science centre, the University of Edinburgh is looking at the long-term risk of deep vein thrombosis and pulmonary embolism after infection with COVID-19. Analyses are currently ongoing, but results are anticipated soon.

This work is funded by the British Heart Foundation and the Stroke Association, with support from Health Data Research UK.

The Scottish Government is not funding research specifically investigating links between long-COVID and deep vein thrombosis (DVT). However, both direct research funding and research support funding has been provided to projects that are investigating the longer term effects of COVID-19.

On December 22 2020, the Chief Scientist Office announced the outcome of its funding call for Scottish-led research on the long-term effects of COVID-19 infection. Following a competitive independently peer reviewed process 9 long-COVID research projects were funded with a total funding commitment of around £2.5 million. Details of the funded projects are available from the Chief Scientist Office website.

Long Covid Call – Chief Scientist Office (scot.nhs.uk)

Scottish Government were advised of Mr Alexander’s death by NHS Ayrshire & Arran on 16 February 2021. At that time, the Board also confirmed that a review was ongoing to determine Reporting of Injuries, Diseases and Dangerous Occurrence Regulations (RIDDOR) reportable status. They further advised that the Health and Safety Executive had been advised by telephone of the death of a member of staff and that NHS Ayrshire & Arran would submit a RIDDOR notification if the internal review indicated this requirement.

Scottish Government has since been advised that in accordance with Health and Safety Executive COVID-19 RIDDOR guidance, Mr Alexander’s death was not, and has not, been formally reported to the Health and Safety Executive as it did not meet the requirements for reporting under RIDDOR.

Scottish Ambulance Service staffing is up 63.5% under this Government, by 2,346.1 WTE between Sept 2006 and June 2021, and now stands at 6,040.4 WTE.

In terms of specific numbers of paramedics in post since 2017, this is detailed in the following table:

The cervical screening programme routinely invites anyone with a cervix who is between the ages of 25 and 64 for a test every 5 years. This is in line with the recommendation given by the UK National Screening Committee (UK NSC), to change the primary screening test from cytology (looking at cervical cells through a microscope to find those which could develop into cancer) to testing for high-risk human papillomavirus (HPV). The new test is more effective at identifying those at risk of developing cervical cancer, meaning those who don’t have HPV will be invited for a cervical screening test every five years instead of every three. The Scottish Government, along with the rest of the UK, is advised on all aspects of cervical screening including the move to HPV testing by the UK NSC.

Further information on the UK NSC’s recommendation can found on the following website: https://view-health-screening-recommendations.service.gov.uk/cervical-cancer/.

The Scottish Government is clear that we wish to maintain and advance the high standards Scotland has enjoyed as part of the EU. Ministers have no current plans to use the discretionary powers to align with the European Union legislation provided through the UK Withdrawal from the EU (Continuity) (Scotland) Act 2021 in the area of nature restoration legislation.

Ministers will set out a statement of policy on the factors to be taken into account when considering whether to use the discretionary power within the UK Withdrawal from the EU (Continuity) (Scotland) Act 2021 in the coming months .

The Scottish Government does not hold information on the newborn hearing test and newborn infant physical examination. These would need to be requested from health boards directly.

The following table shows the number of babies screened using the bloodspot test in the newborn screening programme between January 2019 and July 2021.

It is important to note that the data provided below is management information and has not been subject to the necessary quality checks carried out for an official publication.

As part of the NHS Scotland response to coronavirus (COVID-19), an Innovation Workstream has been created to manage the evaluation of antibody and swab (PCR) tests. This workstream is led by NHS NSS and clinical scientists from NHS Health Boards, and is designed to take advantage of rapid innovations within testing, while at the same time avoiding duplication of effort between Health Boards.

As part of this workstream, antibody tests being used within Scotland are validated by NHS Scotland. The evaluation reports for the antibody assays which have currently been validated and are in use are publicly available, and can be found on NHS Scotland’s Health Innovation Assessment Portal . These evaluation reports show the high sensitivity and specificity of antibody tests approved for use within Scotland.

Scotland is also part of the UK National Testing Programme, participating in UK-wide antibody studies such as the Post Positive PCR Antibody Testing Initiative, where antibody tests have been validated by the UK Government. These validation reports are publicly available, and can be found on the UK Government website .